These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23533767)

  • 1. Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles.
    Jimbow K; Ishii-Osai Y; Ito S; Tamura Y; Ito A; Yoneta A; Kamiya T; Yamashita T; Honda H; Wakamatsu K; Murase K; Nohara S; Nakayama E; Hasegawa T; Yamamoto I; Kobayashi T
    J Skin Cancer; 2013; 2013():742925. PubMed ID: 23533767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review.
    Tamura Y; Ito A; Wakamatsu K; Kamiya T; Torigoe T; Honda H; Yamashita T; Uhara H; Ito S; Jimbow K
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of re-challenge B16 melanoma transplant by conjugates of melanogenesis substrate and magnetite nanoparticles as the basis for developing melanoma-targeted chemo-thermo-immunotherapy.
    Takada T; Yamashita T; Sato M; Sato A; Ono I; Tamura Y; Sato N; Miyamoto A; Ito A; Honda H; Wakamatsu K; Ito S; Jimbow K
    J Biomed Biotechnol; 2009; 2009():457936. PubMed ID: 19830247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cells.
    Sato M; Yamashita T; Ohkura M; Osai Y; Sato A; Takada T; Matsusaka H; Ono I; Tamura Y; Sato N; Sasaki Y; Ito A; Honda H; Wakamatsu K; Ito S; Jimbow K
    J Invest Dermatol; 2009 Sep; 129(9):2233-41. PubMed ID: 19295615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma-targeted chemo-thermo-immuno (CTI)-therapy using N-propionyl-4-S-cysteaminylphenol-magnetite nanoparticles elicits CTL response via heat shock protein-peptide complex release.
    Sato A; Tamura Y; Sato N; Yamashita T; Takada T; Sato M; Osai Y; Okura M; Ono I; Ito A; Honda H; Wakamatsu K; Ito S; Jimbow K
    Cancer Sci; 2010 Sep; 101(9):1939-46. PubMed ID: 20594194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of putative neo-antigen formation from N-propionyl-4-S-cysteaminylphenol, a tyrosinase substrate, in melanoma models.
    Ito S; Nishigaki A; Ishii-Osai Y; Ojika M; Wakamatsu K; Yamashita T; Tamura Y; Ito A; Honda H; Nakayama E; Jimbow K
    Biochem Pharmacol; 2012 Sep; 84(5):646-53. PubMed ID: 22728921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell receptor repertoires of tumor-infiltrating lymphocytes after hyperthermia using functionalized magnetite nanoparticles.
    Ito A; Yamaguchi M; Okamoto N; Sanematsu Y; Kawabe Y; Wakamatsu K; Ito S; Honda H; Kobayashi T; Nakayama E; Tamura Y; Okura M; Yamashita T; Jimbow K; Kamihira M
    Nanomedicine (Lond); 2013 Jun; 8(6):891-902. PubMed ID: 23066648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma.
    Ito A; Fujioka M; Yoshida T; Wakamatsu K; Ito S; Yamashita T; Jimbow K; Honda H
    Cancer Sci; 2007 Mar; 98(3):424-30. PubMed ID: 17270032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs.
    Thomas PD; Kishi H; Cao H; Ota M; Yamashita T; Singh S; Jimbow K
    J Invest Dermatol; 1999 Dec; 113(6):928-34. PubMed ID: 10594732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
    Jimbow K
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumour effect of the melanogenesis-based antimelanoma agent N-propionyl-4-S-cysteaminylphenol.
    Tandon M; Thomas PD; Shokravi M; Singh S; Samra S; Chang D; Jimbow K
    Biochem Pharmacol; 1998 Jun; 55(12):2023-9. PubMed ID: 9714323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Events in the Melanogenesis Cascade as Novel Melanoma-Targeted Small Molecules: Principle and Development.
    Wakamatsu K; Ito A; Tamura Y; Hida T; Kamiya T; Torigoe T; Honda H; Ito S; Jimbow K
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and selective in vitro anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol.
    Yukitake J; Otake H; Inoue S; Wakamatsu K; Olivares C; Solano F; Hasegawa K; Ito S
    Melanoma Res; 2003 Dec; 13(6):603-9. PubMed ID: 14646624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro anti-cancer efficacy of multi-functionalized magnetite nanoparticles combining alternating magnetic hyperthermia in glioblastoma cancer cells.
    Minaei SE; Khoei S; Khoee S; Vafashoar F; Mahabadi VP
    Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():575-587. PubMed ID: 31029351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity.
    Gili A; Thomas PD; Ota M; Jimbow K
    Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Size dependent heat generation of magnetite nanoparticles under AC magnetic field for cancer therapy.
    Motoyama J; Hakata T; Kato R; Yamashita N; Morino T; Kobayashi T; Honda H
    Biomagn Res Technol; 2008 Oct; 6():4. PubMed ID: 18928573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-induced cellular damage and tolerance in combination with adriamycin for the PC-3 prostate cancer cell line: relationships with cytotoxicity, reactive oxygen species and heat shock protein 70 expression.
    Moriyama-Gonda N; Igawa M; Shiina H; Urakami S; Wada Y; Terashima M
    Eur Urol; 2000 Aug; 38(2):235-40. PubMed ID: 10895018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol.
    Prezioso JA; Wang N; Bloomer WD
    Cancer Chemother Pharmacol; 1992; 30(5):394-400. PubMed ID: 1505078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploitation of pigment biosynthesis pathway as a selective chemotherapeutic approach for malignant melanoma.
    Jimbow K; Iwashina T; Alena F; Yamada K; Pankovich J; Umemura T
    J Invest Dermatol; 1993 Feb; 100(2 Suppl):231S-238S. PubMed ID: 8433013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide conjugated magnetic nanoparticles for magnetically mediated energy delivery to lung cancer cells.
    Hauser AK; Anderson KW; Hilt JZ
    Nanomedicine (Lond); 2016 Jul; 11(14):1769-85. PubMed ID: 27388639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.